![FUNCTIONAL SAFETY CERTIFICATE - Total Valve Control · FUNCTIONAL SAFETY CERTIFICATE ... failures: [h-1] λDD λDU 0 ... The PFDAVG figure shown is for illustration only assuming](https://static.fdocument.org/doc/165x107/5b351c597f8b9aec518cedac/functional-safety-certificate-total-valve-functional-safety-certificate-.jpg)
Contract Research Organization Quality Control...
1
Page 1 of 1 ._____________________________________________________________________________________________________________________ . Eργαστήρια Εφαρμοσμένης Βιομηχανικής Έρευνας & Ανάλυσης Α.Ε. Laboratories of Applied Industrial Research & Analysis S.A. .ΑΜΥΚΛΩΝ 26, 15231 ΧΑΛΑΝΔΡΙ, ΑΘΗΝΑ AMYKLON 26 STR., 15231 HALANDRI, ATHENS - GREECE .ΤΗΛ : 210 6755652, 6773625 - FAX : 210 6773625 - e-mail: [email protected] - http://www.skylab-med.gr - TEL : (+30) 210 6755652, 6773625 - FAX : (+30) 210 6773625 Contract Research Organization Quality Control Laboratories CERTIFICATE OF ANALYSIS No R160183474 / 15.01.2016 RESULTS Test code Method Analyses Results CRG-60 Solid Phase Micro Extraction-Gas Chromatography (SPME/GC-FID) Diacetyl <0.5 μg/ml (LOQ) Acetyl Propionyl <0.1 μg/ml (LOQ) CRG-72 Acetoin <0.5 μg/ml (LOQ) Note : The term LOQ (limit of quantification) refers to the determination limit of the method For Acetoin, Diacetyl is 0.5 μg/ml and for Acetyl Propionyl is 0.1 μg/ml. SIGNATURE Dr. Nicoletta Yannovits Analytical Dept. Manager Attn: Mr. Chr.Kanavakis Client: OMNIA e-LIQUIDS, 4 N.Efessos Str., GR-16121, Kaisariani, Athens, Greece. Tel: +2121042717 Sample description: E-Liquid (for electronic cigarette)- ready for use Client labeling: “OMNIA e-LIQUIDS-Hustler 9 mg/ml, 50%VG/50%PG, Expiry date: 02/12/17’’ Skylab-Med reference: 1512-1382/01 Sample packaging / sample weight: Plastic container (vial), (1)× ~30ml. Sampling: Client Transport: Courier Received on: 16/12/2015 Condition upon receipt: Normal Analyses duration: 11-15/01/2016 Accredited tests are identified by the symbol ∗. Skylab-Med laboratories hold a GMP license from National Drug Organisation, EOF (Authorisation Nr 0000009612/11/1). The results refer solely to the submitted sample(s).The present analytical report may only be reproduced in full and only with the written approval of Skylab-Med.
Transcript of Contract Research Organization Quality Control...
Page 1 of 1
._____________________________________________________________________________________________________________________
. Eργαστήρια Εφαρμοσμένης Βιομηχανικής Έρευνας & Ανάλυσης Α.Ε. Laboratories of Applied Industrial Research & Analysis S.A. .ΑΜΥΚΛΩΝ 26, 15231 ΧΑΛΑΝΔΡΙ, ΑΘΗΝΑ AMYKLON 26 STR., 15231 HALANDRI, ATHENS - GREECE
.ΤΗΛ : 210 6755652, 6773625 - FAX : 210 6773625 - e-mail: [email protected] - http://www.skylab-med.gr - TEL : (+30) 210 6755652, 6773625 - FAX : (+30) 210 6773625
Contract Research Organization Quality Control Laboratories
CERTIFICATE OF ANALYSIS No R160183474 / 15.01.2016
RESULTS
Test code Method Analyses Results
CRG-60 Solid Phase Micro Extraction-Gas
Chromatography (SPME/GC-FID)
Diacetyl <0.5 μg/ml (LOQ)
Acetyl Propionyl <0.1 μg/ml (LOQ)
CRG-72 Acetoin <0.5 μg/ml (LOQ)
Note: The term LOQ (limit of quantification) refers to the determination limit of the method For Acetoin, Diacetyl is 0.5 μg/ml and for Acetyl Propionyl is 0.1 μg/ml. SIGNATURE
Dr. Nicoletta Yannovits Analytical Dept. Manager
Attn: Mr. Chr.Kanavakis Client: OMNIA e-LIQUIDS, 4 N.Efessos Str., GR-16121, Kaisariani, Athens, Greece. Tel: +2121042717 Sample description: E-Liquid (for electronic cigarette)- ready for use Client labeling: “OMNIA e-LIQUIDS-Hustler 9 mg/ml, 50%VG/50%PG, Expiry date: 02/12/17’’ Skylab-Med reference: 1512-1382/01 Sample packaging / sample weight: Plastic container (vial), (1)× ~30ml. Sampling: Client Transport: Courier Received on: 16/12/2015 Condition upon receipt: Normal Analyses duration: 11-15/01/2016
Accredited tests are identified by the symbol ∗. Skylab-Med laboratories hold a GMP license from National Drug Organisation, EOF (Authorisation Nr 0000009612/11/1). The results refer solely to the submitted sample(s).The present analytical report may only be reproduced in full and only with the written approval of Skylab-Med.
